People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biodesix Inc | — | Biotechnology | Series B | $175.4M | $635.0M | 2009 |
Heinrich Roder at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Heinrich Roder on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Miller | 1 | 18 |
| Matthew Strobeck | 1 | 3 |
| Robin Cowie | 1 | 3 |
| Scott Hutton | 1 | 2 |
| Robert Cawthorn | 1 | 2 |
| Frank Ronchetti | 1 | 2 |
| David Brunel | 1 | 2 |
| Jack Schuler | 1 | 2 |
| John Patience | 1 | 2 |
| Robert Georgantas | 1 | 1 |
| Matt Stauffer | 1 | 1 |
| Heinrich Roder, D.Phil. | 1 | 1 |
| Wendy Blosser | 1 | 1 |
| Liz Fliegelman | 1 | 1 |
| Jean Franchi | 1 | 1 |
| Hany Massarany | 1 | 1 |
| Charles Watts | 1 | 1 |
| Bobbi Coffin | 1 | 1 |
| Gary Pestano, Ph.D. | 1 | 1 |
| Jim Purvis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.